vs
GE医疗（DHC）与MARCUS CORP（MCS）财务数据对比。点击上方公司名可切换其他公司
GE医疗的季度营收约是MARCUS CORP的2.0倍（$379.6M vs $193.5M），MARCUS CORP同比增速更快（2.8% vs -0.0%），MARCUS CORP自由现金流更多（$26.4M vs $-166.4M），过去两年MARCUS CORP的营收复合增速更高（18.2% vs 1.2%）
GE医疗是一家总部位于美国伊利诺伊州芝加哥市的医疗科技企业，业务涵盖四大板块：医疗影像设备，包括分子成像、CT、核磁共振、妇科健康筛查及X光系统；超声设备；患者护理解决方案，聚焦远程患者监测、麻醉呼吸护理、心脏诊断及婴幼儿护理；此外还涉及医药相关领域，是全球医疗行业的知名企业。
马库斯公司是一家美国企业，主营商业地产领域相关服务，业务覆盖美国与加拿大，提供商业地产经纪、按揭经纪、行业研究以及咨询服务，首创了由单一经纪公司独家代理房源挂牌的行业模式，目前在美加两国设有超过80家办公室，拥有员工超1800名。
DHC vs MCS — 直观对比
营收规模更大
DHC
是对方的2.0倍
$193.5M
营收增速更快
MCS
高出2.8%
-0.0%
自由现金流更多
MCS
多$192.8M
$-166.4M
两年增速更快
MCS
近两年复合增速
1.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $379.6M | $193.5M |
| 净利润 | $-21.2M | — |
| 毛利率 | — | — |
| 营业利润率 | -12.6% | 0.9% |
| 净利率 | -5.6% | — |
| 营收同比 | -0.0% | 2.8% |
| 净利润同比 | 75.7% | — |
| 每股收益（稀释后） | $-0.09 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DHCMCS
| Q4 25 | $379.6M | $193.5M | ||
| Q3 25 | $388.7M | $210.2M | ||
| Q2 25 | $382.7M | $206.0M | ||
| Q1 25 | $386.9M | $148.8M | ||
| Q4 24 | $379.6M | $188.3M | ||
| Q3 24 | $373.6M | $232.7M | ||
| Q2 24 | $371.4M | $176.0M | ||
| Q1 24 | $370.8M | $138.5M |
净利润DHCMCS
| Q4 25 | $-21.2M | — | ||
| Q3 25 | $-164.0M | $16.2M | ||
| Q2 25 | $-91.6M | $7.3M | ||
| Q1 25 | $-9.0M | $-16.8M | ||
| Q4 24 | $-87.4M | $986.0K | ||
| Q3 24 | $-98.7M | $23.3M | ||
| Q2 24 | $-97.9M | $-20.2M | ||
| Q1 24 | $-86.3M | $-11.9M |
营业利润率DHCMCS
| Q4 25 | -12.6% | 0.9% | ||
| Q3 25 | -43.4% | 10.8% | ||
| Q2 25 | -24.5% | 6.3% | ||
| Q1 25 | -2.7% | -13.7% | ||
| Q4 24 | -26.1% | -1.2% | ||
| Q3 24 | -26.5% | 14.1% | ||
| Q2 24 | -23.0% | 1.3% | ||
| Q1 24 | -23.7% | -12.0% |
净利率DHCMCS
| Q4 25 | -5.6% | — | ||
| Q3 25 | -42.2% | 7.7% | ||
| Q2 25 | -23.9% | 3.6% | ||
| Q1 25 | -2.3% | -11.3% | ||
| Q4 24 | -23.0% | 0.5% | ||
| Q3 24 | -26.4% | 10.0% | ||
| Q2 24 | -26.3% | -11.5% | ||
| Q1 24 | -23.3% | -8.6% |
每股收益（稀释后）DHCMCS
| Q4 25 | $-0.09 | — | ||
| Q3 25 | $-0.68 | — | ||
| Q2 25 | $-0.38 | — | ||
| Q1 25 | $-0.04 | — | ||
| Q4 24 | $-0.37 | — | ||
| Q3 24 | $-0.41 | — | ||
| Q2 24 | $-0.41 | — | ||
| Q1 24 | $-0.36 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $105.4M | $23.4M |
| 总债务越低越好 | $2.4B | $159.0M |
| 股东权益账面价值 | $1.7B | $457.4M |
| 总资产 | $4.4B | $1.0B |
| 负债/权益比越低杠杆越低 | 1.47× | 0.35× |
8季度趋势，按日历期对齐
现金及短期投资DHCMCS
| Q4 25 | $105.4M | $23.4M | ||
| Q3 25 | $201.4M | $7.4M | ||
| Q2 25 | $141.8M | $14.9M | ||
| Q1 25 | $302.6M | $11.9M | ||
| Q4 24 | $144.6M | $40.8M | ||
| Q3 24 | $256.5M | $28.4M | ||
| Q2 24 | $265.6M | $32.8M | ||
| Q1 24 | $207.1M | $17.3M |
总债务DHCMCS
| Q4 25 | $2.4B | $159.0M | ||
| Q3 25 | — | $162.0M | ||
| Q2 25 | — | $179.9M | ||
| Q1 25 | — | $198.9M | ||
| Q4 24 | $3.1B | $159.1M | ||
| Q3 24 | — | $173.1M | ||
| Q2 24 | — | $175.7M | ||
| Q1 24 | — | $169.8M |
股东权益DHCMCS
| Q4 25 | $1.7B | $457.4M | ||
| Q3 25 | $1.7B | $454.3M | ||
| Q2 25 | $1.9B | $448.4M | ||
| Q1 25 | $1.9B | $441.8M | ||
| Q4 24 | $2.0B | $464.9M | ||
| Q3 24 | $2.0B | $462.3M | ||
| Q2 24 | $2.1B | $449.4M | ||
| Q1 24 | $2.2B | $459.3M |
总资产DHCMCS
| Q4 25 | $4.4B | $1.0B | ||
| Q3 25 | $4.7B | $1.0B | ||
| Q2 25 | $4.8B | $1.0B | ||
| Q1 25 | $5.0B | $1.0B | ||
| Q4 24 | $5.1B | $1.0B | ||
| Q3 24 | $5.3B | $1.0B | ||
| Q2 24 | $5.3B | $1.1B | ||
| Q1 24 | $5.3B | $1.0B |
负债/权益比DHCMCS
| Q4 25 | 1.47× | 0.35× | ||
| Q3 25 | — | 0.36× | ||
| Q2 25 | — | 0.40× | ||
| Q1 25 | — | 0.45× | ||
| Q4 24 | 1.56× | 0.34× | ||
| Q3 24 | — | 0.37× | ||
| Q2 24 | — | 0.39× | ||
| Q1 24 | — | 0.37× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-19.6M | $48.8M |
| 自由现金流经营现金流 - 资本支出 | $-166.4M | $26.4M |
| 自由现金流率自由现金流/营收 | -43.8% | 13.6% |
| 资本支出强度资本支出/营收 | 38.7% | 11.6% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-280.3M | $989.0K |
8季度趋势，按日历期对齐
经营现金流DHCMCS
| Q4 25 | $-19.6M | $48.8M | ||
| Q3 25 | $-49.3M | $39.1M | ||
| Q2 25 | $53.0M | $31.6M | ||
| Q1 25 | $-3.2M | $-35.3M | ||
| Q4 24 | $112.2M | $52.6M | ||
| Q3 24 | $21.1M | $30.5M | ||
| Q2 24 | $44.3M | $36.0M | ||
| Q1 24 | $28.6M | $-15.1M |
自由现金流DHCMCS
| Q4 25 | $-166.4M | $26.4M | ||
| Q3 25 | $-89.8M | $18.2M | ||
| Q2 25 | $18.8M | $14.7M | ||
| Q1 25 | $-42.9M | $-58.3M | ||
| Q4 24 | $-89.5M | $27.1M | ||
| Q3 24 | $-26.1M | $12.0M | ||
| Q2 24 | $3.3M | $16.1M | ||
| Q1 24 | $-18.1M | $-30.5M |
自由现金流率DHCMCS
| Q4 25 | -43.8% | 13.6% | ||
| Q3 25 | -23.1% | 8.7% | ||
| Q2 25 | 4.9% | 7.1% | ||
| Q1 25 | -11.1% | -39.2% | ||
| Q4 24 | -23.6% | 14.4% | ||
| Q3 24 | -7.0% | 5.2% | ||
| Q2 24 | 0.9% | 9.2% | ||
| Q1 24 | -4.9% | -22.0% |
资本支出强度DHCMCS
| Q4 25 | 38.7% | 11.6% | ||
| Q3 25 | 10.4% | 9.9% | ||
| Q2 25 | 8.9% | 8.2% | ||
| Q1 25 | 10.2% | 15.5% | ||
| Q4 24 | 53.1% | 13.5% | ||
| Q3 24 | 12.6% | 7.9% | ||
| Q2 24 | 11.0% | 11.3% | ||
| Q1 24 | 12.6% | 11.1% |
现金转化率DHCMCS
| Q4 25 | — | — | ||
| Q3 25 | — | 2.41× | ||
| Q2 25 | — | 4.32× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 53.31× | ||
| Q3 24 | — | 1.31× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DHC
| Senior Housing Operating Portfolio Segment | $323.4M | 85% |
| Rental Income | $56.2M | 15% |
MCS
| Theatres | $123.1M | 64% |
| Concessions | $51.0M | 26% |
| Food And Beverage | $21.2M | 11% |
